Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits

Amato, 2008, Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification, Cochrane Database of Systematic Reviews, 3, CD005031 Anoro, 2003, Barcelona’s safer injection facility – EVA: A harm reduction program lacking official support, Journal of Drug Issues, 33, 689, 10.1177/002204260303300309 Bravo, 2009, Use of supervised injection facilities and injection risk behaviours among young drug injectors, Addiction (Abingdon, England), 104, 614, 10.1111/j.1360-0443.2008.02474.x Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), 2015 de la Fuente, 2006, Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes, Journal of Epidemiology and Community Health, 60, 537, 10.1136/jech.2005.037333 European Monitoring Centre for Drugs and Drug Addiction, 2016 Gowing, 2008 Kerr, 2017, Supervised injection facilities in Canada: Past, present, and future, Harm Reduction Journal, 14, 28, 10.1186/s12954-017-0154-1 Kerr, 2005, Safer injection facility use and syringe sharing in injection drug users, Lancet, 366, 316, 10.1016/S0140-6736(05)66475-6 Kinnard, 2014, Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark, Harm Reduction Journal, 11, 29, 10.1186/1477-7517-11-29 Marshall, 2011, Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: A retrospective population-based study, Lancet, 377, 1429, 10.1016/S0140-6736(10)62353-7 Potier, 2014, Supervised injection services: What has been demonstrated? A systematic literature review, Drug and Alcohol Dependence, 145, 48, 10.1016/j.drugalcdep.2014.10.012 Reddon, 2011, Use of North America’s first medically supervised safer injecting facility among HIV-positive injection drug users, AIDS Education and Prevention, 23, 412, 10.1521/aeap.2011.23.5.412 Scherbaum, 2010, Longitudinal observation of a sample of german drug consumption facility clients, Substance Use & Misuse, 45, 176, 10.3109/10826080902873044 Small, 2012, Perceptions of risk and safety within injection settings: Injection drug users’ reasons for attending a supervised injecting facility in Vancouver, Canada, Health, Risk & Society, 14, 307, 10.1080/13698575.2012.680950 Stoltz, 2007, Changes in injecting practices associated with the use of a medically supervised safer injection facility, Journal of Public Health, 29, 35, 10.1093/pubmed/fdl090 Vecino, 2013, Apertura de espacios de consumo higiénico y actuaciones policiales en zonas con fuerte tráfico de drogas. evaluación mediante el recuento de las jeringas abandonadas en el espacio público, Adicciones, 25, 333, 10.20882/adicciones.35 Wood, 2004, Methodology for evaluating Insite: Canada’s first medically supervised safer injection facility for injection drug users, Harm Reduction Journal, 1, 9, 10.1186/1477-7517-1-9 Wood, 2006, Service uptake and characteristics of injection drug users utilizing North America’s first medically supervised safer injecting facility, American Journal of Public Health, 96, 770, 10.2105/AJPH.2004.057828 Wood, 2007, Rate of detoxification service use and its impact among a cohort of supervised injecting facility users, Addiction, 102, 916, 10.1111/j.1360-0443.2007.01818.x Wood, 2008, Nurse-delivered safer injection education among a cohort of injection drug users: Evidence from the evaluation of Vancouver’s supervised injection facility, The International Journal on Drug Policy, 19, 183, 10.1016/j.drugpo.2008.01.003 World Health Organization, 1994